Ingalls & Snyder LLC Horizon Therapeutics Public LTD CO Transaction History

Ingalls & Snyder LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	BUY	$62.39 - $113.8 $172,196 - $314,088	2,760 New	2,760 $314,000
Q1 2022 May 09, 2022	BUY	$86.42 - $109.81 $1,641 - $2,086	19 Added 0.67%	2,864 $301,000
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $394 - $479	-4 Reduced 0.14%	2,845 $307,000
Q3 2021 Oct 27, 2021	SELL	$91.91 - $110.37 $12,867 - $15,451	-140 Reduced 4.68%	2,849 $312,000
Q2 2021 Aug 03, 2021	SELL	$86.24 - $95.92 $6,123 - $6,810	-71 Reduced 2.32%	2,989 $280,000
Q1 2021 Apr 21, 2021	BUY	$71.83 - $95.48 $11,349 - $15,085	158 Added 5.44%	3,060 $282,000
Q4 2020 Jan 27, 2021	BUY	$67.0 - $84.39 $11,725 - $14,768	175 Added 6.42%	2,902 $212,000
Q3 2020 Oct 21, 2020	BUY	$55.23 - $79.93 $150,612 - $217,969	2,727 New	2,727 $212,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

Stay updated on Ingalls & Snyder LLC with notifications on news.